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OBJECTIVES We sought to prospectively assess the diagnostic yielding of a protocol in which electrophysi-
ologic studies (EPS), tilt-table tests (TTTs), and loop recorder implantation are selectively
used.
BACKGROUND The optimal strategy in the diagnosis of patients with syncope of unknown cause has not been
defined.
METHODS A total of 184 consecutive patients with syncope of unknown cause were classified into two
groups. Group A consisted of 72 patients fulfilling any of the following criteria: 1) presence
of structural heart disease or family history of sudden death; 2) abnormal electrocardiogram;
3) significant non-symptomatic arrhythmia on Holter monitoring; and 4) paroxysmal
palpitations immediately before or after syncope. These patients initially underwent an EPS
and, if this study was negative, TTT. In the remaining 112 patients (group B), TTT was
performed
RESULTS The EPS was positive in 32 patients (44%) in group A. The TTT was positive in 80 patients
(71%) in group B. An additional patient had carotid sinus hypersensitivity. In patients of
group A with a negative EPS, the TTT was positive in 23 (57%). A loop recorder was
implanted in 15 patients from group A with negative conventional testing, and diagnostic
activation was obtained in seven patients. Overall, a positive diagnosis was achieved in 143
patients (78%).
CONCLUSIONS In patients with syncope of unknown cause, selective use of EPS or TTT leads to a positive
diagnosis in70% of the cases. An implantable loop recorder can be useful in non-diagnosed
cases. (J Am Coll Cardiol 2003;41:787–90) © 2003 by the American College of Cardiology
Foundation
The etiology of syncope is difficult to establish in patients
with syncope of a non-apparent cause after the initial
clinical assessment. These patients are frequently referred
for an electrophysiologic study (EPS) (1–3) and tilt-table
testing (TTT) (2–4). Although the isolated value of these
tests has been assessed in several studies, there is a lack of
information about the diagnostic value of a protocol that
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selectively uses both tests. However, this information is
important because, as has been suggested recently, a diag-
nostic strategy with initial use of an implantable loop
recorder (ILR) can be superior to conventional testing (5).
This study prospectively assessed the diagnostic yielding of
a protocol in which EPS, TTT, and ILR were selectively
used.
METHODS
Patients. We studied 184 consecutive patients (113 men
and 71 women; mean age 54.5  17.4 years) with syncope
of unknown cause after an initial clinical examination.
Patients were referred by the Emergency Department or the
general practitioner to the Cardiology Outpatient Clinic for
an initial clinical evaluation. All patients had at least a
syncopal episode in the previous two years. The initial
clinical assessment included a careful history, a physical
examination, an electrocardiogram (ECG), a carotid sinus
massage, postural blood pressure testing, and 24-h ambu-
latory monitoring. Other tests were performed if clinically
indicated.
Study protocol. Based on the results of a previous retro-
spective study (6), a two-step diagnostic protocol was
developed and approved at our institution.
1. In accordance with the results of the initial evaluation
and after giving informed, written consent, patients were
classified into two groups. Group A consisted of 72
patients fulfilling any of the following criteria: 1) the
presence of structural heart disease or family history of
sudden death; 2) an abnormal ECG; 3) significant
non-symptomatic arrhythmia on Holter monitoring (si-
nus pause 2 s, second-degree atrioventricular [AV]
block, asymptomatic supraventricular or ventricular
tachycardia); and 4) paroxysmal palpitations before or
immediately after the episode. These patients initially
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underwent EPS. Group B comprised the remaining 112
patients in which TTT was performed.
2. All patients from group A with a negative EPS under-
went TTT; and, if this was negative, an ILR (Reveal,
Medtronic Inc., Minneapolis, Minnesota) was im-
planted, and the patients were instructed to activate the
device after every episode of syncope or presyncope.
EPS. An EPS was performed as previously described (6)
and was considered diagnostic in the presence of: 1) an
abnormal sinus node recovery time; 2) baseline HV interval
70 ms, or second- or third-degree His-Purkinje block, as
demonstrated during incremental atrial pacing or elicited by
intravenous administration of procainamide (10 mg/kg over
10 min); 3) induction of sustained monomorphic ventricular
tachycardia; and 4) induction of a rapid supraventricular
arrhythmia that reproduced hypotensive or spontaneous
symptoms.
TTT. A TTT was performed to 60° during 20 min. If the
passive tilt phase did not induce syncope, 0.4 mg of
sublingual nitroglycerin spray was administered, and the tilt
continued for 15 min (7). The TTT was considered positive
if a syncopal episode associated with a rapid fall in blood
pressure with or without associated bradycardia was in-
duced.
Statistical analysis. Data are presented as the mean value
 SD and as group percentages. Group comparisons were
performed by using the Mann-Whitney U test for contin-
uous variables and the Fisher exact test for dichotomous
variables. A p value 0.05 was considered statistically
significant.
RESULTS
The clinical characteristics of patients in groups A and B are
shown in Table 1. The results of EPS and TTT are shown
in Figure 1. In group A, the EPS was positive in 32 patients
(44%). The diagnoses in these patients included paroxysmal
AV block in 14 (43%), ventricular tachycardia in nine
(28%), supraventricular tachycardia in five (16%), sinus node
dysfunction in three (9%), and a previously unrecognized
carotid sinus hypersensitivity in one patient.
In group B, a syncopal episode was induced in 80 patients
(71%) during TTT, and carotid sinus hypersensitivity was
detected in one patient of this group.
Of the 40 patients of group A with a negative EPS, the
TTT was positive in 23 (57%). Therefore, with the selective
use of EPS, TTT, and repeated carotid sinus massage, a
positive diagnosis was found in 136 patients (74%).
An ILR was implanted in 15 patients of group A with
negative conventional testing, whereas the remaining two
patients refused implantation. During the follow-up period
of 7.8  4.7 months, an ILR-documented syncopal event
occurred in eight patients after a mean period of 81.3 
96.4 days. The mechanism of syncope was paroxysmal AV
Abbreviations and Acronyms
ATP  adenosine triphosphate
AV  atrioventricular
ECG  electrocardiogram, electrocardiographic
EPS  electrophysiologic study/studies
ILR  implantable loop recorder
TTT  tilt-table test(s)/testing
Table 1. Characteristics of Patients in Groups A and B
Group A
(n  72)
Group B
(n  112) p Value
Mean age (yrs) 59  14 51  18 0.002
Mean age at first episode of syncope (yrs) 54  18 44  21 0.001
Male gender 52 (72%) 61 (54%) 0.02
History of syncope
No. of episodes last year 4.6  7 3.9  9 NS
No. of episodes in last 3 months 2.4  5 1.4  2 NS
No. of presyncopal episodes last year 3.8  8 2.6  5 NS
Patients with trauma 26 (36%) 46 (41%) NS
Patients with severe trauma 7 (10%) 14 (13%) NS
Associated structural heart disease 35 (49%) —
Ischemic 17 —
Hypertrophic 8 —
Dilated 4 —
Valvular 2 —
Others 4 —
Heart failure 8 (11%) —
Abnormal ECG 52 (72%) —
Intraventricular conduction defect 27 —
Abnormal Holter recording 22 (31%) —
Palpitations in episode 17 (24%) —
Family history of sudden death 1 (1.4%) —
Data are presented as the mean value  SD or number (%) of patients.
ECG  electrocardiogram; NS  not significant.
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block in three patients with an intraventricular conduction
defect, sinus arrest in two patients, and polymorphic ven-
tricular tachycardia in two patients. One patient showed
sinus rhythm during the syncopal episode, so no positive
diagnosis was obtained. None of the two patients with
polymorphic ventricular tachycardia had structural heart
disease. One patient had a family history of sudden death,
and the other had borderline idiopathic QT prolongation
(0.48 s). Eventually, a diagnosis was obtained in 143
patients (78%).
DISCUSSION
The main finding of the present study is that selective use of
conventional techniques (EPS and TTT) is associated with
a high diagnostic yield in non-selected cases of syncope of
unknown cause. The performance of a diagnostic protocol
of syncope is clearly influenced by patient selection. In the
present study, the presence of at least one syncopal episode
in the previous two years and a negative initial clinical
work-up were the only conditions for being included.
In our study, we assigned patients to group A or B in
order to: 1) be sensitive in the detection of potential lethal
arrhythmias without excessively increasing the number of
EPS; 2) diagnose as many patients as possible; and 3) save
time and costs.
The EPS is the most suitable test for the detection of
potentially lethal arrhythmias. The yield of abnormal results
with this technique varies between 11% and 75% in distinct
series (1,2,8,9), mainly reflecting differences in patient
selection. In one study (9), an LV ejection fraction 40%,
the absence of structural heart disease, a normal 12-lead
ECG, and the absence of significant arrhythmias on Holter
monitoring were predictive criteria of a non-diagnostic
EPS. On the other hand, palpitations were the only signif-
icant predictor of a cardiac cause of syncope in patients
without heart disease (10). So, the clinical criteria used in
the present study should define a group B in which the EPS
had a low diagnostic yield and a group A in which most of
the patients with arrhythmic syncope would be included.
The positive rate of EPS in this study was relatively low
(44%). The EPS has a limited sensitivity to detect parox-
ysmal AV block (11). Some studies have shown that EPS
has a poor predictive value in patients with dilated cardio-
myopathy, poor LV function, and syncope, making advis-
able the implantation of an automatic defibrillator in those
patients (12,13).
A TTT potentiated with sublingual nitroglycerin has
showed a positive rate of 69% in patients with syncope of
unknown cause and 8% in control subjects (7). In our study,
the selection criteria made patients in group B have a high
pre-test probability of vasovagal syncope. So, the high rate
of positive TTT (71%) observed in this group is in accor-
dance with the expected figure. In patients of group A with
a negative EPS, a high TTT positivity rate was also found.
This is in accordance with previous reports in which TTT
was performed in patients with a previous negative EPS
(2,14).
To get a maximal diagnostic yield in patients of group A,
we implanted an ILR in patients of this group with negative
conventional testing, and syncope recurred in 50%. Pro-
longed monitoring results suggest that this is a heteroge-
neous subgroup including patients with paroxysmal AV
block, polymorphic ventricular tachycardia, and neurome-
diated syncope.
In patients of group B with a negative TTT, no more
diagnostic tests were scheduled. There is general agreement
that in this group of patients, EPS is not a useful strategy
(3). In a similar subgroup, ILR monitoring has shown
evidence of a very good prognosis, with 34% recurrence of
syncopal episodes, suggestive of neurally mediated syncope
in most cases (15). In the present study, we decided not to
systematically implant an ILR in patients with isolated
syncope, because we believed that the benign nature, the low
recurrence rate, and the uniform type of response of these
cases do not justify an invasive approach and the additional
cost of an ILR.
Comparison with previous studies. There are no pub-
lished data on the diagnostic value of a protocol similar to
ours. In the study of Sra et al. (2), 86 consecutive patients
with syncope of unknown cause underwent EPS that was
positive in 29 (34%). A TTT was done in the remaining 57
Figure 1. Results of electrophysiologic studies (EPS) and tilt-table testing
(TTT) in groups A and B. Figures represent the number of patients, with
group percentage in brackets. CSH  carotid sinus hypersensitivity.
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patients and was positive in 34 (58%). So, the overall
positive diagnosis with this protocol (74%) is similar to that
obtained in the conventional phase of our protocol, in which
an EPS was performed in only 39% of patients.
The results of the present study are markedly different
from those obtained by Krahn et al. (5). In their study, 60
patients with unexplained syncope were randomized to
conventional testing (EPS and TTT) or prolonged moni-
toring with an ILR. After crossover, a diagnosis was
obtained in 55% of the patients with prolonged monitoring,
compared with 19% in the conventional testing branch.
However, young patients without structural heart disease
and patients with significant structural heart disease were
both excluded. The exclusion of patients with a high
pre-test probability of vasovagal syncope or arrhythmic
syncope was responsible for the low diagnostic yield of the
conventional approach observed in that study.
Study limitations. In our study, an adenosine triphosphate
(ATP) test was not performed. It is possible that the
addition of an ATP test to our protocol could increase the
diagnostic yield (16,17).
As in other studies of syncope, an abnormal EPS or TTT
response was considered to be a surrogate of the true cause
of syncope. Although the diagnostic criteria used in the
present study are commonly accepted, the significance of
these criteria in a concrete subgroup of patients (for exam-
ple, in patients of group A with a negative EPS and a
positive TTT) would be clarified, in the future, by the
results of long-term follow-up and by comparing them with
the results of prolonged ILR monitoring (18).
Conclusions. In non-selected patients with syncope of
unknown cause after the initial clinical evaluation, selective
use of EPS or TTT guided by relatively simple clinical
criteria leads to a positive diagnosis in more than 70% of
cases. The use of an ILR in non-diagnosed cases increases
the diagnostic success.
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